# Post-market Prospective, Multicenter, Randomized and Single-blinded Clinical Investigation to Evaluate Whether Cardiac Re-Synchronization Therapy (CRT) Using Automatic Continuous Atrioventricular (AV) Delay Optimization is Superior to CRT With Conventional Biventricular Stimulation (BiV).

> **NCT06044597** · NA · NOT_YET_RECRUITING · sponsor: **Antonio Rapacciuolo** · enrollment: 722 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** SyncAV function on

## Key facts

- **NCT ID:** NCT06044597
- **Lead sponsor:** Antonio Rapacciuolo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-10-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-10-30
- **Target enrollment:** 722 (ESTIMATED)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06044597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06044597, "Post-market Prospective, Multicenter, Randomized and Single-blinded Clinical Investigation to Evaluate Whether Cardiac Re-Synchronization Therapy (CRT) Using Automatic Continuous Atrioventricular (AV) Delay Optimization is Superior to CRT With Conventional Biventricular Stimulation (BiV).". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06044597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*